David focuses on intellectual property litigation in the pharmaceutical and biotechnology industries. His practice includes representing clients in federal district courts and before the Patent Trial and Appeal Board (PTAB). He has extensive experience in Hatch-Waxman litigation and provides strategic support to clients navigating complex legal disputes in the life sciences sector.